Medical Condition News

RSS

Ethnicity and the effect of potentially modifiable risk factors on dementia

The effects of potentially modifiable risk factors on dementia vary among people of South Asian, Black, and White ethnicities.

12 Oct 2023

Genetic causes of Raynaud’s phenomenon identified

Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of Raynaud’s phenomenon. Their findings, published today (12 October) in Nature Communications, could lead to the first effective treatments for people with Raynaud’s.

12 Oct 2023

University of Manchester's new publication offers insight on causes and challenges of poor mental health

The University of Manchester has marked World Mental Health Day today (10 October) with the launch of a new publication offering insight on the causes and challenges of poor mental health, together with a suite of recommendations to help policymakers improve the lives of millions.

12 Oct 2023

Analysis suggests the need for pharma research into non-motor symptoms of Parkinson’s disease

Analysis of the online conversations among patients with Parkinson’s Disease suggests a need for pharmaceutical research to be targeted at treating the non-motor symptoms of the disease.

12 Oct 2023

Early pregnancy obesity linked to heart risks and complicated births

Study reveals a significant link between obesity in early pregnancy and adverse pregnancy outcomes, which in turn are associated with elevated cardiovascular disease risk later in life. The findings suggest the importance of early interventions to mitigate long-term health risks.

12 Oct 2023

Could young blood be the key to reversing age-related cognitive decline?

Researchers at the University of Auckland identify platelet factor 4 (PF4) in young blood as a key player in reversing age-related cognitive decline in mice. The study offers a promising avenue for treating dementia-related conditions and enhancing brain function in aging populations.

11 Oct 2023

New AI software achieves 100% detection rate for melanoma

Skin cancer detection using artificial intelligence (AI) software has rapidly improved, new research has shown, with the latest software reaching a 100% detection rate for melanoma.

11 Oct 2023

Saline injection treatment for calcific tendinopathy provides no meaningful benefit over placebo

A saline injection treatment widely used for calcific tendinopathy - a common, painful condition caused by a build-up of calcium in the rotator cuff tendons of the shoulder - provides no meaningful benefit over placebo, concludes a trial published by The BMJ today.

11 Oct 2023

Is "double jeopardy" of midlife and old age stalling America's life expectancy?

Study reveals that the stagnation in U.S. life expectancy since 2010 is more significantly impacted by increased mortality rates in those above 65 years old than in working-age adults. Termed "double jeopardy," this finding highlights the urgent need for targeted interventions to improve health outcomes across age groups.

11 Oct 2023

AI helps neurosurgeons identify brain tumor types on the spot

What type of brain tumor does this patient have? AI technology helps to determine this as early as during surgery, within 1.5 hours. This process normally takes a week.

11 Oct 2023

World-first clinical trial offers new hope in the treatment of mild cognitive impairment among older people

Western Sydney University's NICM Health Research Institute has led a world-first clinical trial in Australia that offers new hope in the treatment of mild cognitive impairment (MCI) among older people.

11 Oct 2023

New glutamine sensor could revolutionize early diagnosis and treatment of geriatric diseases

In 2023, life expectancy in Korea will be 83.6 years, the third highest among OECD countries, and it is steadily increasing every year.

11 Oct 2023

UArizona to train next generation of Alzheimer's researchers with prestigious NIH grant

A prestigious National Institute on Aging training grant to develop a future workforce of research scientists in the field of Alzheimer's disease and related dementias was awarded to researchers at the Center for Innovation in Brain Science at the University of Arizona Health Sciences.

11 Oct 2023

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma is the second most common type of skin cancer in the United States, impacting approximately 700,000 people each year.

11 Oct 2023

BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

A new research paper was published in Oncotarget's Volume 14 on October 4, 2023, entitled, "Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells."

11 Oct 2023

Subtle test deficits may predict risk of developing mild cognitive impairment

Among people who report memory and thinking problems, some show no signs of a problem on standard tests, while others have subtle declines on their tests.

11 Oct 2023

New consensus practice guideline published for clinicians on the determination of brain death

New guidance has been issued for clinicians on the determination of brain death, also known as death by neurologic criteria.

11 Oct 2023

Study reveals a microbial metabolite's role in inducing Parkinson's-like symptoms

Researchers from the University of Vienna, University of Konstanz, and Albert Einstein College of Medicine uncover a potential environmental trigger for Parkinson's disease.

11 Oct 2023

Study highlights YB-1 targeting as novel treatment approach for pleural mesothelioma

Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options.

11 Oct 2023

Study identifies pathways explaining racial/ethnic and socio-economic disparities in dementia

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 18, entitled, "Pathways explaining racial/ethnic and socio-economic disparities in dementia incidence: the UK Biobank study."

11 Oct 2023

Medical Condition News

Ethnicity and the effect of potentially modifiable risk factors on dementia

Genetic causes of Raynaud’s phenomenon identified

University of Manchester's new publication offers insight on causes and challenges of poor mental health

Analysis suggests the need for pharma research into non-motor symptoms of Parkinson’s disease

Early pregnancy obesity linked to heart risks and complicated births

Could young blood be the key to reversing age-related cognitive decline?

New AI software achieves 100% detection rate for melanoma

Saline injection treatment for calcific tendinopathy provides no meaningful benefit over placebo

Is "double jeopardy" of midlife and old age stalling America's life expectancy?

AI helps neurosurgeons identify brain tumor types on the spot

World-first clinical trial offers new hope in the treatment of mild cognitive impairment among older people

New glutamine sensor could revolutionize early diagnosis and treatment of geriatric diseases

UArizona to train next generation of Alzheimer's researchers with prestigious NIH grant

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

Subtle test deficits may predict risk of developing mild cognitive impairment

New consensus practice guideline published for clinicians on the determination of brain death

Study reveals a microbial metabolite's role in inducing Parkinson's-like symptoms

Study highlights YB-1 targeting as novel treatment approach for pleural mesothelioma

Study identifies pathways explaining racial/ethnic and socio-economic disparities in dementia

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News